Drug giant agrees to acquire sleep-aid developer Hypnion.
|
With $8.5 billion to play with, New Enterprise Associates brings in a new partner.
|
Early-stage biotech startups seek more funding to clear hurdles associated with product development.
|
Archus Orthopedics snares $35 million in a third round of financing.
|
Buyout shops and mezzanine funds raised 67 percent more last year.
|
Biopharma and medical devices scored in 2005. Buyers want to get in early.
|
The week of December 12 features a feast of 18 initial public offerings including eight from the tech sector.
|
Newly formed Clarus Ventures plans to invest in mid- to late-stage companies.
|
Deal flow improves for angel investors as venture firms snub early-stage investments.
|